期刊文献+

异种MMP-2 DNA疫苗联合伽玛刀治疗胶质瘤实验研究 被引量:1

Research on treatment of active immunogene with vaccine based on chicken homologous matrix metalloproteinases-2 combined with gamma knife surgery on gliomas
在线阅读 下载PDF
导出
摘要 目的通过对荷瘤裸小鼠进行异种基质金属蛋白酶-2(c-MMP-2)DNA疫苗联合伽玛刀(γ-刀)治疗胶质瘤,观察二者的协同治疗作用,并对其作用机制进行初步探讨。方法制备纯化c-MMP-2 DNA疫苗,裸鼠腋下注入大鼠C6胶质瘤细胞株1×106/只,建立裸鼠胶质瘤动物模型,待肿瘤长至约1cm(接种后第16d)开始治疗。γ-刀治疗以50%的等剂量曲线覆盖,边缘剂量13Gy;异种MMP-2 DNA疫苗治疗组小鼠自荷瘤后次日开始后肢肌肉注射c-MMP-2 DNA疫苗(1mg/ml),100μl/次,每周一次,连续4w。观察瘤体大小、测量肿瘤重量;免疫组化法测肿瘤组织微血管密度;末端脱氧核苷酸转移酶介导的生物素脱氧尿嘧啶核苷酸缺口标记法(TUNEL)检测各组肿瘤细胞凋亡指数;HE染色观察重要器官组织坏死情况。结果异种MMP-2 DNA疫苗联合γ-刀治疗胶质瘤能明显抑制肿瘤组织的生长,并延长荷瘤小鼠的生存期,与其他3组比较,联合治疗组免疫组化显示小鼠的肿瘤组织中微血管密度明显减少;TUNEL显示凋亡指数明显增多。结论c-MMP-2 DNA疫苗联合γ-刀治疗能够抑制肿瘤生长、抑制肿瘤血管生成,二者的联合应用具有协同效应,是一种独特的抗肿瘤治疗途径。 Objective To investigate whether the sustained expression of chicken matrix metalloproteinases-2 (c-MMP-2) combined with gamma knife surgery (GKS) could enhance the therapy efficacy on gliomas. Methods Constructed c-MMP-2 DNA vaccine plasmids for DNA vaccination were purified by using two rounds of passage over endo-frec columns. Glioma model were established. Briefly, C6 cells, which were prepared as a single-cell suspension in sterile phosphate buffered solution (PBS) at concentration of 5 ×10^9/l and volume of 100 μl ×10^6/ 200μl cells, viability 97% ) were injected i.m. into armpit of 5 to 6 w female BALB/C nude mice. When the volume of tuner grew into 1 cm, GKS performed with prescription curve of 50% and prescription dose of 13 Gy. 100 μl c- MMP-2 (1 mg/ml) i.m. was performed once weekly for 4 w on 1 st day after inoculation of tuner cells. Tumor size was recorded. After the completion of therapy, Microvessel density (MVD) were evaluated by immunohistochemtry (CD 31 ) and tumor apoptesis were evaluated by terminal deoxynucleotidy transferease-mediated biotingtaled dcoxyuridine triphoephate nick-end labehng (TUNEL). Results As compared with three other control groups, the combined treatment group with GKS and c-MMP-2 gene significantly reduced tumor volume and prolonged the life span of tuner burden mice as well. In addition, the average tumor weight was lower in GKS combined with c-MMP- 2 group than any others control groups. Inmmunohistochemical analysis of C6 gliomas demonstrated that the significant decrease of MVD in tuner tissne and a higher apoptesis cell rate in GKS combined with c-MMP-2 group. Conclusion The antitumor effect of GKS can be realized by e-MMP-2 gene therapy. These findings suggest a promising way to overcome tumor radiotherapy resistance by antiangiogenic gene therapy.
出处 《中华神经外科疾病研究杂志》 CAS 2008年第1期46-50,共5页 Chinese Journal of Neurosurgical Disease Research
关键词 异种基质金属蛋白酶-2 DNA疫苗 伽玛刀 胶质瘤 Chicken matrix metalloproteinases-2 Gamma knife surgery Glioma
作者简介 陈兢,讲师,博士,电话:(028)85422485,E—mail:jchen6811@tom.com 通讯作者:蔡博文,主治医师,电话:(028)81812518,E—mail:cbw0903@hotmail.com
  • 相关文献

参考文献12

  • 1Chen CH, Ji H, Sun KW, et al. Gene gun-mediated DNA vaccination induces antitumor immunity against human papilomavirus type 16 E7- expressing murine tumor metastases in the liver and lungs [ J ]. Gene Ther, 1999, 6(12) : 1972 - 1981.
  • 2O-charoenrat P, Modjtahedi H, Rhys-Evans P, et al. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells [ J ]. Cancer Res, 2000, 60(4) : 1121 - 1128.
  • 3Arbiser JL, Moses MA, Fernandez CA, et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways [ J ]. Proc Natl Acad Sci USA, 1997, 94(3): 861 -866.
  • 4Ahmad I, Filep JJ, Franklin JC, et al. Enhanced therapeutic effects of liposome-associated 1 -O-octadecyl-2-O-methyl-sn-glycero-3-phospho choline [J]. Cancer Res, 1997, 57(10) : 1915 - 1921.
  • 5Su JM, Wei YQ, Tian L, et al. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2 [ J ]. Cancer Res, 2003, 63 (3) : 600 - 607.
  • 6牛朝诗,徐纪文,罗其中.裸鼠胶质瘤模型的建立及其病理[J].安徽医科大学学报,2000,35(2):98-100. 被引量:9
  • 7Wei YQ, Huang MJ, Yang L, et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen [J]. Proc Natl Acad Sci USA, 2001, 98 (20) : 11545 - 11550.
  • 8He QM, Wei YQ, Tian L, et al. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice [J]. J Biol Chem, 2003, 278 (24): 21831 - 21836.
  • 9Horton HM, Anderson D, Hernandez P, et al. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha [J]. Proc Natl Acad Sci USA, 1999, 96(4) : 1553 - 1558.
  • 10Wei YQ, Wang QR, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells a vaccine [J]. Nat Med, 2000, 6(10) : 1160 - 1166.

二级参考文献6

  • 1Antunes L,Angioi-Duprez KS,Bracard SR,et al.Analysis of tissue chimerism in nude mouse brain and abdominal xenograft models of human glioblastoma multiforme:what does it tell us about the models and about glioblastoma biology and therapy[J] ? J Histochem Cytochem,2000,48(6):847-858.
  • 2Yamada S,Khankaldyyan V,Bu X,et al.A method to accurately inject tumor cells into the caudate/putamen nuclei of the mouse brain[J].Tokai J Exp Clin Med,2004,29(4):167-173.
  • 3Mishima K,Mazar AP,Gown A,et al.A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin[J].Proc Natl Acad Sci USA,2000,97(15):8484-8489.
  • 4Bu X,Khankaldyyan V,Gonzales-Gomez I,et al.Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism[J].Lab Invest,2004,84(6):667-678.
  • 5Taga T,Suzuki A,Gonzalez-Gomez I,et al.alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin[J].Int J Cancer,2002,98(5):690-697.
  • 6Zagzag D,Miller DC,Sato Y,et al.Immunohistochemical localization of basic fibroblast growth factor in astrocytomas[J].Cancer Res,1990,50(22):7393-7398.

共引文献21

同被引文献13

  • 1李彦和,徐德生,浦佩玉,康春生,董伦,贾强,郑立高,王广秀.p53联合伽玛刀治疗抑制人脑胶质瘤细胞生长的体外研究[J].立体定向和功能性神经外科杂志,2006,19(4):196-200. 被引量:4
  • 2CUDDIHY A R, BRISTOW R G. The P53 protein family and radiation sensitivity: yes or no [J]? Cancer Metastasis Rev, 2004, 23(3-4): 237-257.
  • 3GUDKOV A V, KOMAROVA E A. The role of p53 in determining sensitivity to radiotherapy [J]. Nat Rev Cancer, 2003, 3(2): 117-129.
  • 4CROWLEY R W, POURATIAN N, SHEEHAN J P. Gamma knife surgery for glioblastoma multiforme [J]. Neurosurg Focus, 2006, 15; 20(4): E17.
  • 5KONG D S, LEE J I, PARK K, et al. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas [J]. Cancer, 2008, 112(9): 2046-2051.
  • 6ULM A J 3RD, FRIEDMAN W A, BRADSHAW P, et al. Radiosurgery in the treatment of malignant gliomas: the University of Florida experience [J]. Neurosurgery, 2005, 57 (3): 512-517.
  • 7HARRIS S L, LEVINE A J. The p53 pathway: positive and negative feedback loops [J]. Oncogene, 2005, 18; 24(17): 2899-2908.
  • 8DRIDI W, FETNI R, LAVOIE J, et al. The dominantnegative effect of p53 mutants and p21 induction in tetraploid G1 arrest depends on the type of p53 mutation and the nature of the stimulus [J]. Cancer Genet Cytogenet, 2003, 143(1): 39-49.
  • 9YAN W, LIU G, SCOUMANNE A, et al. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations [J]. Cancer Res, 2008, 68(16): 6789-6796.
  • 10FEI P, El-DEIRY W S, P53 and radiation responses [J]. Oncogene, 2003, 22(37): 5774-5783.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部